ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1479

Qualitative Assessment of Patient Important Long-Term Outcomes in Juvenile Idiopathic Arthritis

Melissa L. Mannion1, Michelle Williams2, Nataliya Ivankova3, Gerald McGwin Jr.4, Kenneth G. Saag5 and Timothy Beukelman6, 1Pediatrics, University of Alabama at Birmingham, Birmingham, AL, 2School of Public Health, University of Alabama at Birmingham, Birmingham, AL, 3Health Services Administration, University of Alabama at Birmingham, Birmingham, AL, 4Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama at Birmingham, Birmingham, AL, 6Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: juvenile idiopathic arthritis (JIA), outcome measures and qualitative

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The aim of this study was to identify and characterize the factors that JIA patients in young adulthood use to define a successful disease outcome, with the ultimate goal of creating an outcome assessment tool to provide a gold-standard for comparing different treatment approaches for JIA.

Methods: In depth personal interviews were conducted with adolescents (ages 14-18) and young adults (ages 19-40) with JIA and parents of children with JIA to generate themes regarding successful treatment, acceptable disease states, and optimal disease management outcomes for young adults with JIA.  Interviews were recorded and transcribed; then they were coded using in vivo coding to generate mutually exclusive categories that were further combined into themes and quantized.  The outcome topic categories were also quantized based on the number of participants who mentioned the category. Outcome themes were compared to themes generated from interviews with pediatric rheumatologists. 4 adolescents with JIA, 6 young adults with JIA, and 10 parents of children with JIA were interviewed with representation of all US census regions. 13 pediatric rheumatologists from the US were interviewed. 

Results:  The initial in vivo codes were regrouped into 15 outcome topics and quantized; chronic arthritis/joint damage, physical/functional, medication, pain/fatigue, expectations, vocation/profession, social/participation, daily life/activities of daily living, health, vision, family, independence, appearance, mental health, and community.  The categories with the most patient/parent codes were medication, social/participation, and community while the categories with the most physician codes were chronic arthritis/joint damage, physical/functional, and medication. The categories mentioned by all patients and parents were physical/functional, medication, social/participation, and community. The transcripts were recoded for description of outcomes resulting in 9 mutually exclusive categories; ability, active disease/remission, interference/burden, feel normal, everything that they want to do, understanding, satisfaction, indistinguishable from peers, and acceptance.  The categories with the most patient/parent codes were interference/burden and indistinguishable from peers; the categories with the most physician codes were ability and interference/burden.  Interference/burden was mentioned in all interviews, indistinguishable from peers was mentioned by all patients and parents and ability was mentioned by all physicians.

Conclusion: This study begins to characterize the factors that adolescents with JIA, young adults with JIA, and parents of children with JIA use to define a successful disease outcome for JIA in young adulthood. Patients prioritize medication burden and effects, social and participation impacts, and the idea of a supportive community in the definition of successful JIA management. With additional studies, the definition of a gold standard based on physician and patient input will enable patients to be better informed about their treatment options and expected future outcomes.


Disclosure: M. L. Mannion, None; M. Williams, None; N. Ivankova, None; G. McGwin Jr., None; K. G. Saag, None; T. Beukelman, UCB, 5,Genentech/Roche, 5,Novartis Pharmaceutical Corporation, 5.

To cite this abstract in AMA style:

Mannion ML, Williams M, Ivankova N, McGwin G Jr., Saag KG, Beukelman T. Qualitative Assessment of Patient Important Long-Term Outcomes in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/qualitative-assessment-of-patient-important-long-term-outcomes-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/qualitative-assessment-of-patient-important-long-term-outcomes-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology